GLP-1 drugs — bone/gout/osteo risks + regain + menopause weight
Key Questions
What are the bone and muscle risks of GLP-1 drugs without proper support?
Without protein intake, resistance training, and creatine, GLP-1 drugs carry a 30% increased risk of osteoporosis and muscle loss. Menopause compounds these challenges with increased intramuscular adipose tissue.
How common is weight regain after stopping GLP-1 medications?
Up to 70% of users regain weight after discontinuation. Long-term success requires sustained protein intake of 1.2-1.5 g/kg plus fiber.
Why is HRT alone often insufficient for menopause belly fat?
HRT does not function as a weight-loss drug and fails to fully address visceral fat accumulation. Stacking with GLP-1s and resistance training yields better results.
What nutrition strategies help with menopause weight management on GLP-1s?
Emphasize higher protein targets and fiber-rich foods to preserve muscle and support satiety. Testosterone may offer additional brain, heart, and bone benefits.
How does resistance training mitigate GLP-1 side effects in menopause?
It counters muscle and bone loss while improving body composition. Combined with adequate protein, it addresses regain and menopause-specific weight challenges.
30% osteo/musc risk w/o prot/RT/creat; 70% regain; focus protein 1.2-1.5g/kg + fiber; menopause IMAT/CV/belly weight challenges. HRT alone insufficient for belly fat; stack with GLP-1s and resistance training; testosterone for brain/heart/bone benefits.